Zota Healthcare Intrinsic Value
Zota Healthcare (ZOTA) median intrinsic value is ₹396.57 from 3 valuation models (range ₹379–₹434), vs current price ₹1085.40 — -63.5% downside (Trading Above Calculated Value), margin of safety -100.0%. Read Zota Healthcare dividend payments for the complete payout history and dividend yield track record.
ZOTA Valuation Methods Summary — DCF, Graham Number & P/E
Zota Healthcare intrinsic value across 3 models vs current price ₹1085.40 — upside/downside and value range per method. Analyse Zota Healthcare ownership structure to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹396.57 | ₹356.91 - ₹436.23 | -63.5% | Book Value/Share: ₹198.29, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹379.43 | ₹341.49 - ₹417.37 | -65.0% | Revenue/Share: ₹189.71, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹434.16 | ₹390.74 - ₹477.58 | -60.0% | EBITDA: ₹24.00Cr, EV/EBITDA: 10x |
ZOTA Intrinsic Value vs Market Price — All Valuation Models
Zota Healthcare fair value range ₹379–₹434 vs current market price ₹1085.40 across 3 valuation models. For current market price and key ratios, visit ZOTA share price screener.
ZOTA Intrinsic Value Analysis — Undervalued or Overvalued?
Zota Healthcare median intrinsic value ₹396.57, current price ₹1085.40 — Trading Above Calculated Value by 63.5%, margin of safety -100.0%.
What is the intrinsic value of ZOTA?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Zota Healthcare (ZOTA) is ₹396.57 (median value). With the current market price of ₹1085.40, this represents a -63.5% variance from our estimated fair value.
The valuation range spans from ₹379.43 to ₹434.16, indicating ₹379.43 - ₹434.16.
Is ZOTA undervalued or overvalued?
Based on our multi-method analysis, Zota Healthcare (ZOTA) appears to be trading above calculated value by approximately 63.5%.
ZOTA Financial Health — Key Ratios vs Industry Benchmarks
Zota Healthcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.31 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -8.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 2.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.59x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
ZOTA Cash Flow Quality — Operating & Free Cash Flow
Zota Healthcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-50 Cr | ₹-96 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-6 Cr | ₹-13 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹13 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |
| March 2021 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |